AbGenomics

AltruBio Taiwan, Inc. focuses on patients who need the most help and independently develops "First-In-Class" drugs with novel mechanisms of action, striving to make them the "Best-In-Class" therapeutic drugs.AltruBio Taiwan, Inc. has multiple new drugs in the U.S. clinical trial stage. Through a model of independent development and licensing partnerships, the company efficiently brings its new drugs to the medical market to restore patients' health.